IS6448A - Bakteríuskæð 3-amónóqínazólin-2.4díon hrifefni - Google Patents

Bakteríuskæð 3-amónóqínazólin-2.4díon hrifefni

Info

Publication number: IS6448A
Authority: IS; Iceland
Prior art keywords: amonoquinazole; bacterial properties; bacterial; properties
Prior art date: 2000-01-24

Application number

IS6448A

Other languages

English (en)

Inventor

Bird Paul

Peter Sanchez Joseph

Andrew Stier Michael

Yip Judy

Daniel Showalter Howard

Lee Ellisworth Edmund

Phong Tran Tuan

Quoc Nguyen Dai

Singh Rajeshwar

Morgan Watson Brian

Original Assignee

Warner-Lambert Company, , Delaware Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-01-24

Filing date

2002-06-27

Publication date

2002-06-27

2002-06-27 Application filed by Warner-Lambert Company, , Delaware Corporation filed Critical Warner-Lambert Company, , Delaware Corporation

2002-06-27 Publication of IS6448A publication Critical patent/IS6448A/is

Links

230000001580 bacterial effect Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Communicable Diseases (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Paper (AREA)

IS6448A 2000-01-24 2002-06-27 Bakteríuskæð 3-amónóqínazólin-2.4díon hrifefni IS6448A (is)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US17825200P	2000-01-24	2000-01-24
US24126700P	2000-10-18	2000-10-18
PCT/US2000/033656 WO2001053273A1 (en)	2000-01-24	2000-12-12	3-aminoquinazolin-2,4-dione antibacterial agents

Publications (1)

Publication Number	Publication Date
IS6448A true IS6448A (is)	2002-06-27

Family

ID=26874138

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6448A IS6448A (is)	2000-01-24	2002-06-27	Bakteríuskæð 3-amónóqínazólin-2.4díon hrifefni

Country Status (38)

Country	Link
US (2)	US7094780B1 (is)
EP (1)	EP1255739B1 (is)
JP (1)	JP4811978B2 (is)
KR (1)	KR20020067701A (is)
CN (1)	CN1425008A (is)
AP (1)	AP2002002603A0 (is)
AR (1)	AR030186A1 (is)
AT (1)	ATE398110T1 (is)
AU (1)	AU783078B2 (is)
BG (1)	BG107023A (is)
BR (1)	BR0017010A (is)
CA (1)	CA2393802C (is)
CO (1)	CO5320600A1 (is)
CR (1)	CR6709A (is)
DE (1)	DE60039194D1 (is)
EA (1)	EA005585B1 (is)
EE (1)	EE200200412A (is)
ES (1)	ES2304992T3 (is)
GE (1)	GEP20053429B (is)
HK (1)	HK1054237A1 (is)
HN (1)	HN2001000009A (is)
HR (1)	HRP20020696A2 (is)
HU (1)	HUP0204101A3 (is)
IL (1)	IL150393A0 (is)
IS (1)	IS6448A (is)
MA (1)	MA26866A1 (is)
MX (1)	MXPA02005989A (is)
NO (1)	NO20023516D0 (is)
OA (1)	OA12316A (is)
PA (1)	PA8510101A1 (is)
PE (1)	PE20011060A1 (is)
PL (1)	PL356837A1 (is)
SK (1)	SK10572002A3 (is)
SV (1)	SV2001000288A (is)
TN (1)	TNSN01011A1 (is)
UY (1)	UY26551A1 (is)
WO (1)	WO2001053273A1 (is)
YU (1)	YU55902A (is)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE423776T1 (de)	1997-09-15	2009-03-15	Procter & Gamble	Antimikrobielle chinolone, ihre zusammensetzungen und ihre verwendungen
ATE315038T1 (de)	2001-05-30	2006-02-15	Warner Lambert Co	Antibakterielle mittel
AU2002302894A1 (en) *	2001-06-19	2003-01-02	Warner-Lambert Company Llc	Quinazolinediones as antibacterial agents
US6900224B2 (en) *	2002-07-31	2005-05-31	The Procter & Gamble Company	Antimicrobial quinolones, their compositions and uses
WO2005026153A1 (en) *	2003-09-12	2005-03-24	Warner-Lambert Company Llc	Quinazoline-2, 4-diones as antibacterial agents
CA2538420A1 (en) *	2003-09-12	2005-03-24	Warner-Lambert Company Llc	Quinolone antibacterial agents
WO2005049605A1 (en) *	2003-11-18	2005-06-02	Warner-Lambert Company Llc	Antibacterial aminoquinazolidinedione derivatives
WO2006019965A2 (en) *	2004-07-16	2006-02-23	Takeda San Diego, Inc.	Dipeptidyl peptidase inhibitors
GB0416730D0 (en)	2004-07-27	2004-09-01	Novartis Ag	Organic compounds
ES2332529T3 (es) *	2005-01-26	2010-02-08	F. Hoffmann-La Roche Ag	Derivados de fenil-metanona y su empleo como inhibidores del transportador 1 de glicina.
GB0507298D0 (en)	2005-04-11	2005-05-18	Novartis Ag	Organic compounds
US7977346B2 (en)	2006-01-17	2011-07-12	Guoqing Paul Chen	Spiro compounds and methods of use
PT2001862E (pt)	2006-03-28	2011-07-20	Warner Chilcott Co Llc	Sais de malato e polimorfos do ácido (3s,5s)-7-[3- amino-5-metil-piperidinil]-1-ciclopropil-1,4-dihidro- 8-metoxi-4-oxo-3-quinolinocarboxílico
BRPI0709220A2 (pt)	2006-03-28	2011-07-12	Procter & Gamble	processo de acoplamento para preparo de intermediários de quinolona
US20080139574A1 (en)	2006-11-30	2008-06-12	Cadila Healthcare Limited	Novel quinoline derivatives
MY153733A (en) *	2008-01-30	2015-03-13	Shin Poong Pharmaceutical Co	Novel quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same
WO2011031745A1 (en)	2009-09-09	2011-03-17	Achaogen, Inc.	Antibacterial fluoroquinolone analogs
WO2012088266A2 (en)	2010-12-22	2012-06-28	Incyte Corporation	Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
TWI527818B (zh)	2011-03-15	2016-04-01	特留斯治療學有限公司	三環旋轉酶抑制劑
DK2796460T3 (en) *	2011-12-21	2018-08-27	Jiangsu Hengrui Medicine Co	SEXUAL PYRROL HETEROARYL RING DERIVATIVES, METHOD OF PREPARATION AND MEDICAL APPLICATIONS THEREOF
US9611267B2 (en)	2012-06-13	2017-04-04	Incyte Holdings Corporation	Substituted tricyclic compounds as FGFR inhibitors
US9388185B2 (en)	2012-08-10	2016-07-12	Incyte Holdings Corporation	Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
US10865216B2 (en)	2012-09-12	2020-12-15	Merck Sharp & Dohme Corp.	Tricyclic Gyrase inhibitors
US9266892B2 (en)	2012-12-19	2016-02-23	Incyte Holdings Corporation	Fused pyrazoles as FGFR inhibitors
TWI649318B (zh)	2013-04-19	2019-02-01	英塞特控股公司	作為ｆｇｆｒ抑制劑之雙環雜環
US10851105B2 (en)	2014-10-22	2020-12-01	Incyte Corporation	Bicyclic heterocycles as FGFR4 inhibitors
MA41551A (fr)	2015-02-20	2017-12-26	Incyte Corp	Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
AU2016219822B2 (en)	2015-02-20	2020-07-09	Incyte Holdings Corporation	Bicyclic heterocycles as FGFR inhibitors
WO2016134294A1 (en)	2015-02-20	2016-08-25	Incyte Corporation	Bicyclic heterocycles as fgfr4 inhibitors
CN108530448A (zh) *	2017-03-02	2018-09-14	浙江司太立制药股份有限公司	含有碱性氮杂螺环片段的苯并噻嗪-4-酮类化合物及其制备方法
AR111960A1 (es)	2017-05-26	2019-09-04	Incyte Corp	Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
TW201946630A (zh)	2018-05-04	2019-12-16	美商英塞特公司	Fgfr抑制劑之鹽
ES2991427T3 (es)	2018-05-04	2024-12-03	Incyte Corp	Formas sólidas de un inhibidor de FGFR y procedimientos para preparar las mismas
CN111620866A (zh) *	2019-02-27	2020-09-04	南京药石科技股份有限公司	一种顺式-7,7-二氟-六氢-1H 吡咯并[3,4-c]吡啶衍生物及其制备方法
US11628162B2 (en)	2019-03-08	2023-04-18	Incyte Corporation	Methods of treating cancer with an FGFR inhibitor
WO2021007269A1 (en)	2019-07-09	2021-01-14	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
WO2021067374A1 (en)	2019-10-01	2021-04-08	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
GEAP202415945A (en)	2019-10-14	2024-04-25	Incyte Corp	Bicyclic heterocycles as fgfr inhibitors
WO2021076728A1 (en)	2019-10-16	2021-04-22	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
CA3163875A1 (en)	2019-12-04	2021-06-10	Incyte Corporation	Tricyclic heterocycles as fgfr inhibitors
AU2020395185A1 (en)	2019-12-04	2022-06-02	Incyte Corporation	Derivatives of an FGFR inhibitor
WO2021146424A1 (en)	2020-01-15	2021-07-22	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
CN111499513B (zh) *	2020-04-24	2023-03-14	上海毕得医药科技股份有限公司	一种2,3,4,5-四溴苯甲酸酯的合成方法
EP4323405A1 (en)	2021-04-12	2024-02-21	Incyte Corporation	Combination therapy comprising an fgfr inhibitor and a nectin-4 targeting agent
AR126101A1 (es)	2021-06-09	2023-09-13	Incyte Corp	Heterociclos tricíclicos como inhibidores de fgfr
CA3220274A1 (en)	2021-06-09	2022-12-15	Incyte Corporation	Tricyclic heterocycles as fgfr inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1068263B (is) *		1959-11-05
FR1203542A (fr) *	1958-02-25	1960-01-19	Rhone Poulenc Sa	Nouveaux dérivés de la phénothiazine comportant en position 10 une chaîne pipérazinique et leurs procédés de préparation
ATE8626T1 (de) *	1980-03-10	1984-08-15	Berri-Balzac Societe Dite:	3-amino-(1h,3h)-2,4-chinazolindionderivate.
GB2097784A (en) *	1981-04-28	1982-11-10	Davidson Dr John Stirton	Dihydrobenzotriazepine diones; aminoquinazoline diones
WO1994014809A1 (de)	1992-12-23	1994-07-07	Byk Gulden Lomberg Chemische Fabrik Gmbh	Anellierte uracilderivate
WO1998018781A2 (en)	1996-10-28	1998-05-07	Versicor, Inc.	Fused 2,4-pyrimidinedione combinatorial libraries, their preparation and the use of fused 2,4-pyrimidinediones derivatives as antimicrobial agents
AU9503998A (en) *	1997-10-28	1999-05-17	Warner-Lambert Company	Novel 7-substituted quinazolin-2,4-diones useful as antibacterial agents
EE200000706A (et) *	1998-05-26	2002-06-17	Warner-Lambert Company	Bitsüklilised pürimidiinid ja bitsüklilised 3,4-dihüdropürimidiinid kui rakkude proliferatsiooni inhibiitorid
ES2249055T3 (es) *	1998-12-11	2006-03-16	F. Hoffmann-La Roche Ag	Derivados de hidrazina.

2000
- 2000-12-12 OA OA1200200210A patent/OA12316A/en unknown
- 2000-12-12 PL PL00356837A patent/PL356837A1/xx not_active Application Discontinuation
- 2000-12-12 CA CA2393802A patent/CA2393802C/en not_active Expired - Fee Related
- 2000-12-12 BR BR0017010-0A patent/BR0017010A/pt not_active Application Discontinuation
- 2000-12-12 YU YU55902A patent/YU55902A/sh unknown
- 2000-12-12 KR KR1020027009515A patent/KR20020067701A/ko not_active Withdrawn
- 2000-12-12 HR HR20020696A patent/HRP20020696A2/hr not_active Application Discontinuation
- 2000-12-12 AP APAP/P/2002/002603A patent/AP2002002603A0/en unknown
- 2000-12-12 IL IL15039300A patent/IL150393A0/xx unknown
- 2000-12-12 EP EP00984246A patent/EP1255739B1/en not_active Expired - Lifetime
- 2000-12-12 GE GE4912A patent/GEP20053429B/en unknown
- 2000-12-12 MX MXPA02005989A patent/MXPA02005989A/es active IP Right Grant
- 2000-12-12 EE EEP200200412A patent/EE200200412A/xx unknown
- 2000-12-12 EA EA200200661A patent/EA005585B1/ru not_active IP Right Cessation
- 2000-12-12 WO PCT/US2000/033656 patent/WO2001053273A1/en not_active Ceased
- 2000-12-12 HK HK03106519.6A patent/HK1054237A1/zh unknown
- 2000-12-12 CN CN00818578A patent/CN1425008A/zh active Pending
- 2000-12-12 HU HU0204101A patent/HUP0204101A3/hu unknown
- 2000-12-12 SK SK1057-2002A patent/SK10572002A3/sk unknown
- 2000-12-12 DE DE60039194T patent/DE60039194D1/de not_active Expired - Lifetime
- 2000-12-12 AT AT00984246T patent/ATE398110T1/de not_active IP Right Cessation
- 2000-12-12 AU AU20899/01A patent/AU783078B2/en not_active Ceased
- 2000-12-12 JP JP2001553275A patent/JP4811978B2/ja not_active Expired - Fee Related
- 2000-12-12 ES ES00984246T patent/ES2304992T3/es not_active Expired - Lifetime
- 2000-12-12 US US10/182,221 patent/US7094780B1/en not_active Expired - Fee Related
2001
- 2001-01-19 PA PA20018510101A patent/PA8510101A1/es unknown
- 2001-01-22 CO CO01004183A patent/CO5320600A1/es not_active Application Discontinuation
- 2001-01-22 TN TNTNSN01011A patent/TNSN01011A1/en unknown
- 2001-01-22 SV SV2001000288A patent/SV2001000288A/es not_active Application Discontinuation
- 2001-01-22 HN HN2001000009A patent/HN2001000009A/es unknown
- 2001-01-22 PE PE2001000066A patent/PE20011060A1/es not_active Application Discontinuation
- 2001-01-22 UY UY26551A patent/UY26551A1/es not_active Application Discontinuation
- 2001-01-23 AR ARP010100278A patent/AR030186A1/es unknown
2002
- 2002-06-27 IS IS6448A patent/IS6448A/is unknown
- 2002-07-19 CR CR6709A patent/CR6709A/es not_active Application Discontinuation
- 2002-07-22 MA MA26734A patent/MA26866A1/fr unknown
- 2002-07-23 NO NO20023516A patent/NO20023516D0/no not_active Application Discontinuation
- 2002-08-22 BG BG107023A patent/BG107023A/xx unknown
2006
- 2006-06-13 US US11/452,121 patent/US7582627B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
WO2001053273A1 (en)	2001-07-26
PE20011060A1 (es)	2001-10-12
CA2393802A1 (en)	2001-07-26
IL150393A0 (en)	2002-12-01
GEP20053429B (en)	2005-01-25
NO20023516L (no)	2002-07-23
AU2089901A (en)	2001-07-31
CO5320600A1 (es)	2003-09-30
EA200200661A1 (ru)	2003-02-27
YU55902A (sh)	2006-01-16
AU783078B2 (en)	2005-09-22
EP1255739A1 (en)	2002-11-13
AP2002002603A0 (en)	2002-09-30
HRP20020696A2 (en)	2003-12-31
BR0017010A (pt)	2002-11-05
EE200200412A (et)	2003-10-15
OA12316A (en)	2006-05-15
HN2001000009A (es)	2001-06-13
PA8510101A1 (es)	2003-06-30
SV2001000288A (es)	2001-11-30
ATE398110T1 (de)	2008-07-15
ES2304992T3 (es)	2008-11-01
US20060287308A1 (en)	2006-12-21
SK10572002A3 (sk)	2003-10-07
US7094780B1 (en)	2006-08-22
HUP0204101A2 (hu)	2003-04-28
MA26866A1 (fr)	2004-12-20
EP1255739B1 (en)	2008-06-11
PL356837A1 (en)	2004-07-12
JP2003520277A (ja)	2003-07-02
HK1054237A1 (zh)	2003-11-21
EA005585B1 (ru)	2005-04-28
US7582627B2 (en)	2009-09-01
CA2393802C (en)	2011-04-19
NO20023516D0 (no)	2002-07-23
JP4811978B2 (ja)	2011-11-09
KR20020067701A (ko)	2002-08-23
HUP0204101A3 (en)	2004-05-28
CN1425008A (zh)	2003-06-18
MXPA02005989A (es)	2002-10-23
CR6709A (es)	2003-11-25
DE60039194D1 (de)	2008-07-24
US20060183762A1 (en)	2006-08-17
AR030186A1 (es)	2003-08-13
BG107023A (en)	2003-04-30
TNSN01011A1 (en)	2005-11-10
UY26551A1 (es)	2001-04-30

Publication	Publication Date	Title
IS6448A (is)	2002-06-27	Bakteríuskæð 3-amónóqínazólin-2.4díon hrifefni
MXPA03000059A (es)	2003-10-15	Derivados de pirazol.
EP1197749A4 (en)	2009-05-20	BIOSENSOR
EP1223425A4 (en)	2003-06-04	BIOSENSOR
EP1347292A4 (en)	2005-03-02	BIOSENSOR
EP1314978A4 (en)	2005-06-22	BIOSENSOR
EP1296141A4 (en)	2007-05-30	BIOZENSOR
BR0113116B1 (pt)	2010-09-08	banheira.
DE60123142D1 (de)	2006-11-02	Biosensor
MA25850A1 (fr)	2003-07-01	Conjugues de pro-parfums photolabiles.
EP1202059A4 (en)	2003-01-15	BIOSENSOR
NL1017075A1 (nl)	2001-07-11	Preparaat.
MX242679B (es)	2006-12-14	Antranilamidas insecticidas.
MXPA03001148A (es)	2003-06-09	Antibioticos macrolidos.
FI20000004A0 (fi)	2000-01-03	Flavonoidilääke...
BR0200521B1 (pt)	2011-01-25	artigo higiênico.
AR028607A1 (es)	2003-05-14	Derivados de 1,4-diazepan-2,5-diona
CH695519A5 (de)	2006-06-15	Sperrstromthyristor.
EP1343870A4 (en)	2005-07-13	BACTERIAL EXPRESSION
DE10191181D2 (de)	2003-02-27	Nachweis von Diarrhogenen E.Coli-Keimen
NL1014850A1 (nl)	2001-10-09	Grafkist.
ES1046656Y (es)	2001-06-16	Microplanta de transferencia de residuos solidos urbanos.
ITRM20000040U1 (it)	2001-09-06	Easy playnet.
DE10104914B4 (de)	2005-03-10	Lager
ES1045504Y (es)	2001-03-01	Mueble expositor de piezas ceramicas.